6 completed, 4 recruiting, 1 not yet recruiting. 11 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 11 | Completed 6, Recruiting 4, Not yet recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Healhty: new trials by email Literature Review of Healhty trials Research Report on Healhty
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of NN2802, an Anti-c-Kit Antibody, in Healthy Participants and in Adults With Chronic Spontaneous Urticaria (CSU) NN2802 - Healhty, Chronic Spontaneous Urticaria (CSU) | Phase 1 / Phase 2 | Recruiting | Novelty Nobility, Inc. | 46 | 2026-10-15 | 2026-11-12 |
| Pharmacokinetics of Huperzine A Oral Solution in Healthy Participants Huperzine A Oral Solution, Placebo - Healhty | Phase 1 | Not yet recruiting | Wanbangde Pharmaceutical Group Co., LTD | 40 | 2026-08-25 | 2026-08-25 |
| Safety, Tolerability, Pharmacokinetic and Pharmacodynamic of IY-828026 in Healthy Volunteers IY-828026, Placebo, IY-828026A - Healhty | Phase 1 | Recruiting | Il-Yang Pharm. Co., Ltd. | 86 | 2026-03-23 | 2026-03-27 |
| A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and the Food Effect of HSK55879 Tablets in Healthy Subjects. HSK55879, Placebo - Healhty | Phase 1 | Recruiting | Haisco Pharmaceutical Group Co., Ltd. | 46 | 2026-03-20 | 2026-04-09 |
| A Study to Assess Effect of Dosing Intervals on Multiple-Dose Pharmacokinetics of WD-1603 Taken Before Meals in Healthy Participants Carbidopa and Levodopa Controlled-Release Tablets (25 mg/150 mg) - Healhty | Phase 1 | Completed | Shanghai WD Pharmaceutical Co., Ltd. | 12 | 2026-03-17 | 2026-09-23 |
| Acute Analgesic Effects of MDMA on Experimentally Induced Acute Pain, Hyperalgesia and Allodynia in Healthy Participants MDMA 25 mg, MDMA 75 mg, MDMA 125 mg - Healhty | Phase 1 | Recruiting | University Hospital, Basel, Switzerland | 20 | 2026-03-09 | 2026-03-27 |
| Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM1812 Injection Following Single and Multiple Subcutaneous Administration in Normal to Overweight or Obese But Otherwise Healthy Men and Women BGM1812, Placebo - Healhty, Overweight or Obesity | Phase 1 | Completed | BrightGene Bio-Medical Technology Co., Ltd. | 60 | 2025-10-09 | 2026-11-13 |
| Bioequivalence of Sitagliptin/Metformin Tablets in Healthy Chinese Adults Under Fasting and Fed Conditions Sitagliptin/metformin hydrochloride tablets (50 mg/850 mg), Sitagliptin/metformin hydrochloride reference tablets (50 mg/850 mg) - Healhty | Phase 1 | Completed | Guangzhou Panyu Central Hospital | 56 | 2025-02-27 | 2026-11-02 |
| Study to Evaluate Safety, Tolerability and Pharmacokinetics of G01 Eye Drops in Healthy Volunteers G01 Eye Drops 100 µg/mL SAD, G01 Eye Drops 200 µg/mL SAD, G01 Eye Drops 400 µg/mL SAD - Healhty | Phase 1 | Completed | Qingdao WanMing BioCell Pharmaceutics Co.,Ltd. | 48 | 2024-12-12 | 2026-08-21 |
| Drug-drug Interaction Study Between UIC202304, and UIC202305 UIC202304 and co-administration of UIC202304 and UIC202305, UIC202305 and co-administration of UIC202304 and UIC202305 - Healhty | Phase 1 | Completed | Korea United Pharm. Inc. | 40 | 2023-09-25 | 2026-07-29 |
| Fed Study of Amlodipine and Benazepril HCl Capsules 10 mg/20 mg to Lotrel® Capsules 10 mg/20 mg Amlodipine and Benazepril HCl Capsules 10 mg/20 mg, Lotrel® Capsules 10 mg/20 mg - Healhty | Phase 1 | Completed | Mylan Pharmaceuticals Inc | 64 | 2004-05-01 | 2024-04-24 |
Chronic Urticaria (1) · Obesity (1) · Overweight (1)
Pathological Conditions, Signs and Symptoms (2) · Body Weight (1) · Chronic Disease (1) · Disease Attributes (1) · Hypersensitivity (1) · Hypersensitivity, Immediate (1) · Immune System Diseases (1) · Nutrition Disorders (1) · Nutritional and Metabolic Diseases (1) · Overnutrition (1) · Pathologic Processes (1) · Signs and Symptoms (1) · Skin Diseases (1) · Skin Diseases, Vascular (1) · Skin and Connective Tissue Diseases (1)
Amlodipine (1) · Carbidopa (1) · Metformin (1) · N-Methyl-3,4-methylenedioxyamphetamine (1) · Sagittal Abdominal Diameter (1) · Sitagliptin Phosphate (1) · Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination (1) · benazepril (1) · huperzine A (1) · mycophenolic adenine dinucleotide (1)
BrightGene Bio-Medical Technology Co., Ltd. (1) · Guangzhou Panyu Central Hospital (1) · Haisco Pharmaceutical Group Co., Ltd. (1) · Il-Yang Pharm. Co., Ltd. (1) · Korea United Pharm. Inc. (1) · Mylan Pharmaceuticals Inc (1) · Novelty Nobility, Inc. (1) · Qingdao WanMing BioCell Pharmaceutics Co.,Ltd. (1) · Shanghai WD Pharmaceutical Co., Ltd. (1) · University Hospital, Basel, Switzerland (1) · Wanbangde Pharmaceutical Group Co., LTD (1)
China (6) · South Korea (2) · United States (2) · Switzerland (1)
Dorian Williams, M.D. (1) · Hui Yang (1) · Sung-Dae Kwon, M.D.,Ph.D (1) · Yanmei Liu, Master (1) · Yuzhong Wang (1)